Skip to main content

GOLDMAN SACHS GROUP INC

Position in HAE — Haemonetics Corp

CIK 886982 NEW YORK, NY

Position in HAE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$53,700,933
-$44,612,177 QoQ
Shares Held
952,820
-22.3% QoQ
Ownership
2.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in HAE Over Time

Shares Held

Position Value (USD)

Derivatives in HAE

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$867,944
PutShares
15,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $6,785,897,738 across 94 Medical Devices names. HAE ranks #17 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HAE

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $53,700,933 952,820
2026-03-31 $867,944 15,400
2025-12-31 $98,313,110 1,226,614
2025-12-31 $10,034,780 125,200
2025-09-30 $28,403,429 582,754
2025-06-30 $48,086,144 644,500
2025-03-31 $29,454,217 463,481
2024-12-31 $54,288,710 695,296
2024-09-30 $46,804,066 582,285
2024-06-30 $51,080,148 617,432
2024-03-31 $13,753,810 161,146
2023-12-31 $16,354,043 191,253
2023-09-30 $14,947,227 166,859
2023-06-30 $16,673,986 195,842
2023-03-31 $14,721,968 177,909
2022-12-31 $19,568,354 248,803
2022-09-30 $10,404,989 140,551
2022-06-30 $6,290,977 96,517
2022-03-31 $8,005,548 126,630
2021-12-31 $6,180,167 116,519
2021-09-30 $7,286,440 103,222
2021-06-30 $4,829,333 72,469
2021-03-31 $12,930,221 116,478
2020-12-31 $14,344,999 120,800
2020-09-30 $12,582,757 144,215
2020-06-30 $13,477,525 150,486
2020-03-31 $80,997,667 812,740